Anebulo Pharmaceuticals is Drug Discovery in United States that focus on Anebulo Pharmaceuticals Inc business. Founded in 2020. They cover business area such as Anebulo Pharmaceuticals Inc, novel solution, people, cannabinoid overdose, substance, addiction, administration, symptom, profound sedation, anxiety, panic, psychosis, hallucination.
2020
( 4 years old in 2024 )
Anebulo Pharmaceuticals Inc
-
1415 Ranch Road 620 South
Austin, TX 78734
United States
Private
Anebulo Pharmaceuticals Incnovel solutionpeoplecannabinoid overdosesubstanceaddictionadministrationsymptomprofound sedationanxietypanicpsychosishallucination
* We use standard office opening hours in near Anebulo Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Anebulo Pharmaceuticals is Drug Discovery business from United States that founded in 2020 (4 years old in 2024), Anebulo Pharmaceuticals business is focusing on Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals headquarter office and corporate office address is located in 1415 Ranch Road 620 South Austin, TX 78734 United States.
Anebulo Pharmaceuticals was founded in United States.
In 2024, Anebulo Pharmaceuticals is currently focus on Anebulo Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Anebulo Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Anebulo Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.